-
Mindray Launches TE Air Wireless Handheld Ultrasound Solution in the US Market
•
China-based global device giant Mindray (SHE: 300760) has announced the market launch of its TE Air Wireless Handheld Ultrasound imaging solution in the United States. This innovative device offers healthcare providers (HCPs) a pocket-held scanning tool designed for use across a broad spectrum of clinical scenarios, enhancing diagnostic capabilities at…
-
MSD Plans to Introduce Over 50 New Drugs and Vaccines to China in the Next Five Years
•
Merck, Sharp & Dohme Inc., (MSD, NYSE: MRK), through its China R&D president Li Zhengqing, has shared the company’s pipeline plans with local press. As reported by the China Daily, MSD is planning to introduce over 50 innovative drugs, vaccines, new indications, and companion diagnostics to the Chinese market over…
-
Novo Nordisk and Broad Institute Collaborate on Diabetes and Cardiometabolic Research
•
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has announced a collaboration with the US academic institution, the Broad Institute, on three cutting-edge research projects focusing on diabetes and cardiometabolic diseases. This strategic partnership aims to drive innovation in the understanding and treatment of these conditions. Type 2 Diabetes Drug Target…
-
Janssen’s Rybrevant Combo Meets Primary Endpoint in Advanced NSCLC Study
•
Janssen, a subsidiary of Johnson & Johnson (J&J; NYSE: JNJ), has released an update on a late-stage study for its bispecific antibody (BsAb) Rybrevant (amivantamab). The study investigated the combination of Rybrevant with tyrosine kinase inhibitor (TKI) lazertinib and chemotherapy in treating advanced or metastatic non-small cell lung cancer (NSCLC)…
-
FDA Addresses Looming Migraine Treatment Shortage with Tonix Pharmaceuticals Commitment
•
The US Food and Drug Administration (FDA) is actively engaging with pharmaceutical companies to address an impending shortage of a critical migraine treatment. This follows the UK-based GlaxoSmithKline’s (GSK; NYSE: GSK) decision to discontinue the production of Imitrex (sumatriptan) nasal spray from January 31, 2024. The move has prompted concerns…
-
Henan Zhongshuai’s Dexmethylphenidate Hydrochloride Capsules Target Priority Review for Pediatric ADHD
•
Henan Zhongshuai Pharmaceutical Co., Ltd., a China-based pharmaceutical company, is poised to secure priority review status for its dexmethylphenidate hydrochloride sustained release capsules, which are being developed for potential pediatric use. The molecule is intended to treat attention deficit hyperactivity disorder (ADHD) in children. Phase III Clinical Study and EfficacyThe…
-
Amneal Pharmaceuticals Receives China Approval for Sevelamer Carbonate
•
US-based Amneal Pharmaceuticals Inc. (NYSE: AMRX) has announced that it has received approval from the Chinese market for its sevelamer carbonate, marking the company’s inaugural product approval in China. The drug is indicated for the treatment of hyperphosphatemia in patients with chronic kidney disease who are undergoing dialysis. Sevelamer represents…
-
CSPC Pharmaceutical’s Narlumosbart Approved by NMPA for Bone Giant Cell Tumors
•
CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced that its subsidiary, Shanghai JMT Biotechnology Co., Ltd, has received marketing approval from the National Medical Products Administration (NMPA) for narlumosbart (JMT103), an anti-RANKL monoclonal antibody (mAb), to treat giant cell tumors of bone that are inoperable or may lead to severe…
ADC / XDC AstraZeneca Auto-immune AZ Biotech BMS Bristol-Myers Squibb Cancer CAR-T Cell-therapy Clinical trial approval / initiation Clinical trial results Combination therapy CRO / CMO / CDMO CVD Diabetes Eli Lilly Finance Finanical Reports Gene therapy Hengrui Medicine J&J Johnson & Johnson Market approval filings Merck MSD Multi-specific antibodies NASDAQ: AZN NMPA Novartis NYSE: BMY NYSE: JNJ NYSE: LLY NYSE: MRK NYSE: NVS Obesity Ophthalmology PD-1/L1 Pfizer Potential first-in-class Product approvals Rare / orphan disease drugs SHA: 600276 TKIs (EGFR VEGF BTK etc.) Vaccine
